Ansun’s lead drug candidate, Fludase (DAS181), removes a host cell-surface component used by parainfluenza virus (PIV), influenza virus (IFV), and other viruses to gain entry into host ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback